The Patent Finder
SB

Surgical Biologics, LLC

First filing 2007
OverviewNotableFeesChangesFamiliesPatent listSources & methods

13 patents currently held

30 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Aug 2027. from the record

Of the 30 now held by other companies, 24 were conveyed to MiMedx Group Inc. in the filing they arrived in, and 6 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
13
Ending by 2030
Aug 2027
Next term end
2
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.

Formerly held, still cited

Notable
Cited by 69 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
now held by MiMedx Group, Inc.
Ends Feb 2032 · High confidence
Also notable
Cited by 64 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
conveyed to MiMedx Group, Inc.
Ends Aug 2027 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Sep 1, 2027
    The maintenance fee for Placental Tissue Grafts (US 9,272,003) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Improved Placental Tissue Grafts11 in forceto Oct 2029
Placental Tissue Grafts2 in forceto Aug 2027

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,265,800Placental Tissue Grafts
In force
 · High confidence
In forceHigh confidence
US 9,272,005Placental Tissue Grafts
In force
 · High confidence
In forceHigh confidence
US 8,372,438Method for Inhibiting Adhesion Formation Using an Improved Placental Tissue Graft
In force
 · High confidence
In forceHigh confidence
US 8,372,439Method for Treating a Wound Using Improved Placental Tissue Graft
In force
 · High confidence
In forceHigh confidence
US 8,409,626Improved Placental Tissue Grafts
In force
 · Medium confidence
In forceMedium confidence
US 8,642,092Improved Placental Tissue Grafts
In force
 · Medium confidence
In forceMedium confidence
US 8,703,206Placental Tissue Grafts
In force
 · High confidence
In forceHigh confidence
US 8,703,207Improved Placental Tissue Grafts
In force
 · Medium confidence
In forceMedium confidence
US 8,709,493Placental Tissue Grafts
In force
 · Medium confidence
In forceMedium confidence
US 8,932,643Placental Tissue Grafts
In force
 · Medium confidence
In forceMedium confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 30 patents in force now held by others · 2 patents ended · 2 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
5 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited